Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Filing

See: https://www.sec.gov/Archives/edgar/data/836564/000168316817000031/0001683168-17-000031-index.htm

In my experience these executive agreements get signed, put in the back of the virtual drawer (in this case next to Leckrone's virtual 'done deals' maybe) and left to gather dust. They only get taken out when something is about to happen.

Firing Cliffie after all this time seems unlikely, given what he knows and has witnessed. No severance clause can get around a sub-poena so it's a bit of a stand-off.

My guess is a buy-out or similar is looming. PTSC stock at around 4/1000ths of a dollar values PTSC at under $2M. A million gets you the majority AND ownership of 50% of the MMP.. The shareholders rejected the reverse stock split 9 months back, so it is reasonable to come at it from the other direction.

The clause about Cliff dropping the interim-CEO title but keeping CFO suggests a strategy leading to a new formal CEO but with Cliff Flowers staying around as CFO to file or shred documentation as appropriate.

 

 

 

 

 

Share
New Message
Please login to post a reply